Skip to main content

Table 1 Demographic and clinical characteristics of PLWH at enrollment into the University of Abuja Teaching Hospital HIV Treatment Program

From: Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria

Characteristics

N = 5928

Gender, n (%)

 Male

36.1

 Female

63.9

 Age, mean ± SD years

34.5 ± 8.6

Age, n (%)

 15–24 years

8.7

 25–30 years

23.0

 30–34 years

23.3

 35–39 years

19.6

 40–44 years

11.9

 45–49 years

7.4

 50+ years

6.0

Service entry point, n (%)

 In-patient

5.6

 Outside clinic/program

22.1

 PMTCT

1.7

 VCT

66.2

 Other

3.5

ART regimen, n (%)

 D4T, 3TC, NVP

17.7

 D4T, 3TC, EFV

1.3

 AZT, 3TC, NVP

40.8

 AZT, 3TC, EFV

1.9

 TDF, XTC, NVP

22.0

 TDF, XTC, EFV

14.1

 Others

2.1

WHO stage, n (%)

 1

39.7

 2

24.4

 3

32.0

 4

3.9

 Weight, mean ± SD kg

59.6 ± 17.5

 BMI, mean ± SD kg/m2

23.8 ± 7.0

BMI, n (%)

 < 17 kg/m2

12.1

 17–18.4 kg/m2

7.3

 18.5–24.9 kg/m2

49.7

 25–29.9 kg/m2

20.8

 30+ kg/m2

10.1

 CD4 count, mean ± SD cells/mm3

268 ± 23.7

CD4 Count, n (%)

 < 200 cells/µL

52.2

 200+ cells/µL

88.2

 log10 viral load, mean ± SD copies/mL

3.3 ± 1.3

  1. PMTCT prevention of mother-to-child transmission, VCT voluntary counselling and testing, Mean ± SD mean and standard deviation, n(%) number and percentage, D4T Stavudine, 3TC Lamivudine, NVP nevirapine, EFV efavirenz, AZT zidovudine, TDF tenofovir, XTC emtricitabine, ART antiretroviral therapy, WHO World Health Organisation, BMI body mass index